Annual report pursuant to Section 13 and 15(d)

Stockholders' equity (Tables)

v3.8.0.1
Stockholders' equity (Tables) - Tecogen
12 Months Ended
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Stock Option Activity
Stock option activity for the year ended December 31, 2017 was as follows:
Common Stock Options
Number of
Options
 
Exercise
Price
Per
Share
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Life
 
Aggregate
Intrinsic
Value
Outstanding, December 31, 2016
1,117,918

 
$0.79-$5.39
 
$
3.10

 
5.00 years
 
$
1,415,150

Granted
45,000

 
$3.22-$3.72
 
3.35

 
 
 
 

Assumed in merger
156,124

 
$3.15-$30.33
 
10.35

 
 
 
 
Exercised
(122,043
)
 
$0.79-$2.00
 
1.47

 
 
 
 

Canceled and forfeited
(135,447
)
 
$2.60-30.33
 
9.28

 
 
 
 

Outstanding, December 31, 2017
1,061,552

 
$0.79-$18.15
 
$
3.60

 
4.95 years
 
$
291,449

Exercisable, December 31, 2017
874,202

 
 
 
$
3.46

 
 
 
$
291,449

Vested and expected to vest, December 31, 2017
1,033,450

 
 
 
$
3.58

 
 
 
$
291,449

Summary of Weighted Average Assumptions Used in Black-Scholes Option Pricing
The weighted average assumptions used in the Black-Scholes option pricing model for options granted in 2017 and 2016 are as follows:
Stock option awards:
 
2017
 
2016
Expected life
 
6.25 years
 
6.25 years
Risk-free interest rate
 
1.86%
 
1.22%
Expected volatility
 
23.10%
 
32.80%
Schedule of Restricted Stock Activity
Restricted stock activity for the year ended December 31, 2017 was as follows: 
 
Number of
Restricted
Stock
 
Weighted
Average
Grant Date
Fair Value
Unvested, December 31, 2016
77,508

 
$
1.31

Granted

 

Vested
(34,587
)
 
1.31

Forfeited

 

Unvested, December 31, 2017
42,921

 
$
1.31